WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
1. (WO2001032212) DRUGS, DRINKS OR FOODS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/032212    International Application No.:    PCT/JP2000/007372
Publication Date: 10.05.2001 International Filing Date: 23.10.2000
Chapter 2 Demand Filed:    09.03.2001    
A23F 3/16 (2006.01), A23L 1/30 (2006.01), A23L 1/39 (2006.01), A23L 2/52 (2006.01), A61K 9/00 (2006.01), A61K 31/352 (2006.01), A61K 31/353 (2006.01), C07D 311/60 (2006.01), C07D 311/62 (2006.01)
Applicants: TAKARA SHUZO CO., LTD. [JP/JP]; 609, Takenaka-cho, Fushimi-ku, Kyoto-shi, Kyoto 612-8061 (JP) (For All Designated States Except US).
NISHIYAMA, Eiji [JP/JP]; (JP) (For US Only).
OHNOGI, Hiromu [JP/JP]; (JP) (For US Only).
KONDO, Akihiro [JP/JP]; (JP) (For US Only).
OYASHIKI, Haruo [JP/JP]; (JP) (For US Only).
SAGAWA, Hiroaki [JP/JP]; (JP) (For US Only).
MIZUTANI, Shigetoshi [JP/JP]; (JP) (For US Only).
KATO, Ikunoshin [JP/JP]; (JP) (For US Only)
Inventors: NISHIYAMA, Eiji; (JP).
OHNOGI, Hiromu; (JP).
KONDO, Akihiro; (JP).
OYASHIKI, Haruo; (JP).
SAGAWA, Hiroaki; (JP).
MIZUTANI, Shigetoshi; (JP).
KATO, Ikunoshin; (JP)
Agent: AOYAMA, Tamotsu; Aoyama & Partners, IMP Building 3-7, Shiromi 1-chome, Chuo-ku, Osaka-shi, Osaka 540-0001 (JP)
Priority Data:
11/308013 29.10.1999 JP
2000/224469 25.07.2000 JP
Abstract: front page image
(EN)Remedies or preventives for diseases caused by the binding of agonists (endocrine disruptors, etc.) to the estrogen receptor, characterized by containing, as the active ingredient, antagonists such as catechins (for example, epigallocatechin gallate) having the antagonism to the estrogen receptor agonists.
(FR)Remèdes ou préventifs contre des maladies provoquées par la fixation d'agonistes (perturbateurs du système endocrinien, etc.) au récepteur des oestrogènes, caractérisés en ce qu'ils contiennent, en tant que principe actif, des antagonistes tels que des catéchines (par exemple, le gallate d'épigallocatéchine) présentant l'antagonisme vis-à-vis des agonistes du récepteur des oestrogènes.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)